ATE183387T1 - Pharmazeutische und andere darreichungsformen - Google Patents

Pharmazeutische und andere darreichungsformen

Info

Publication number
ATE183387T1
ATE183387T1 AT93911039T AT93911039T ATE183387T1 AT E183387 T1 ATE183387 T1 AT E183387T1 AT 93911039 T AT93911039 T AT 93911039T AT 93911039 T AT93911039 T AT 93911039T AT E183387 T1 ATE183387 T1 AT E183387T1
Authority
AT
Austria
Prior art keywords
pharmaceutical
forms
pectin
carbon atoms
amino acids
Prior art date
Application number
AT93911039T
Other languages
English (en)
Inventor
Dilip J Gole
Paul K Wilkinson
J Desmond Davies
R Saul Levinson
Original Assignee
Janssen Pharmaceutica Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Inc filed Critical Janssen Pharmaceutica Inc
Application granted granted Critical
Publication of ATE183387T1 publication Critical patent/ATE183387T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F26—DRYING
    • F26B—DRYING SOLID MATERIALS OR OBJECTS BY REMOVING LIQUID THEREFROM
    • F26B5/00—Drying solid materials or objects by processes not involving the application of heat

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT93911039T 1992-05-06 1993-05-03 Pharmazeutische und andere darreichungsformen ATE183387T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87975492A 1992-05-06 1992-05-06

Publications (1)

Publication Number Publication Date
ATE183387T1 true ATE183387T1 (de) 1999-09-15

Family

ID=25374827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93911039T ATE183387T1 (de) 1992-05-06 1993-05-03 Pharmazeutische und andere darreichungsformen

Country Status (27)

Country Link
EP (1) EP0642334B1 (de)
JP (1) JPH07508019A (de)
KR (1) KR100194241B1 (de)
CN (1) CN1085081A (de)
AT (1) ATE183387T1 (de)
BG (1) BG62681B1 (de)
CA (1) CA2135062C (de)
CL (1) CL2004001180A1 (de)
CY (1) CY2175B1 (de)
CZ (1) CZ283882B6 (de)
DE (1) DE69326063T2 (de)
DK (1) DK0642334T3 (de)
ES (1) ES2136662T3 (de)
FI (1) FI111333B (de)
GR (1) GR3031180T3 (de)
HU (2) HU227532B1 (de)
IL (1) IL105553A (de)
MY (1) MY112231A (de)
NO (1) NO308065B1 (de)
NZ (1) NZ252526A (de)
PL (1) PL172354B1 (de)
RO (1) RO112990B1 (de)
RU (1) RU2131244C1 (de)
SG (1) SG47430A1 (de)
SK (1) SK280129B6 (de)
TW (1) TW380053B (de)
WO (1) WO1993023017A1 (de)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5582591A (en) * 1994-09-02 1996-12-10 Delab Delivery of solid drug compositions
US5837276A (en) * 1994-09-02 1998-11-17 Delab Apparatus for the delivery of elongate solid drug compositions
GB9504201D0 (en) * 1995-03-02 1995-04-19 Scherer Ltd R P Process for the preparation of a solid pharmaceutical dosage form
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
DE19539574A1 (de) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
KR100782897B1 (ko) * 1996-06-17 2008-04-08 얀센 파마슈티카 엔.브이. 급속붕괴제형의표시방법
WO1997048384A2 (en) * 1996-06-17 1997-12-24 Janssen Pharmaceutica N.V. Marking rapidly disintegrating dosage forms
KR100823524B1 (ko) * 1996-06-17 2008-11-12 얀센 파마슈티카 엔.브이. 양쪽볼록형급속붕괴제형
DE69710460T2 (de) * 1996-06-17 2002-10-02 Janssen Pharmaceutica N.V., Beerse Bikonvexe, rasch desintegrierende verabreichungsformen
GB9621614D0 (en) * 1996-10-17 1996-12-11 Cultech Limited Vitamin delivery
GB9802088D0 (en) * 1998-01-30 1998-03-25 Scherer Ltd R P Pharmaceutical products
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
DE59800410D1 (de) 1998-11-11 2001-02-01 Dalli Werke Waesche & Koerperp Verdichtetes Granulat, Herstellungsverfahren und Verwendung als Sprengmittel für gepresste Formkörper
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
RU2216319C1 (ru) * 1999-11-30 2003-11-20 Панацея Биотек Лимитед Быстрорастворимая фармацевтическая композиция в виде твердой лекарственной формы с пролонгированным сладким вкусом и способ ее получения
RU2178297C1 (ru) * 2001-02-02 2002-01-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция, обладающая антипсихотическим и противорвотным действием, и способ ее получения
FR2828380B1 (fr) * 2001-08-10 2005-07-29 Fontarome Composition a structure composite contenant des substances aromatiques et/ou des substances non aromatiques volatiles et/ou sensibles aux agents exterieurs, et son procede de fabrication
RU2196338C1 (ru) * 2002-01-28 2003-01-10 Акционерное общество открытого типа "Информационные телекоммуникационные технологии" Способ измерения параметров погруженных в поглощающую среду антенн методом масштабного моделирования, способ приготовления вещества для моделирования поглощающей среды и композиция для приготовления вещества для моделирования поглощающей среды
MXPA04008171A (es) 2002-02-22 2004-11-26 Pharmacia Corp Formulacion oftalmica con sistema de goma.
RU2207129C1 (ru) * 2002-05-07 2003-06-27 Закрытое акционерное общество "Брынцалов-А" Средство, обладающее нейролептическим действием
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10232113A1 (de) 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
WO2004024188A1 (ja) * 2002-09-12 2004-03-25 Nihon Medi-Physics Co., Ltd. 薬物の血漿蛋白質結合を制御するための製剤
US20040052853A1 (en) * 2002-09-16 2004-03-18 Cp Kelco, U.S., Inc. Pectin films
WO2004047793A1 (en) 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
GB0317869D0 (en) * 2003-07-30 2003-09-03 Disperse Ltd Improved drug delivery system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
EP2322195A2 (de) 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin
RU2253442C1 (ru) * 2003-11-14 2005-06-10 Закрытое Акционерное Общество "Канонфарма Продакшн" Защечная (трансбуккальная) фармацевтическая композиция, включающая аминоуксусную кислоту
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
US7939511B2 (en) 2004-09-28 2011-05-10 Senju Pharmaceutical Co., Ltd. Ophthalmic composition containing xanthan gum and amino acid
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005009241A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5632162B2 (ja) * 2007-06-01 2014-11-26 協和発酵バイオ株式会社 経口組成物
CA2713128C (en) 2008-01-25 2016-04-05 Gruenenthal Gmbh Pharmaceutical dosage form
AU2009243681B2 (en) 2008-05-09 2013-12-19 Grunenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
CN102639118B (zh) 2009-07-22 2015-07-29 格吕伦塔尔有限公司 氧化稳定的抗干扰剂型
KR101738369B1 (ko) 2009-07-22 2017-05-22 그뤼넨탈 게엠베하 핫 멜트 압출된 제어 방출 투여형
DK2493457T3 (en) 2009-10-30 2017-10-02 Ix Biopharma Ltd QUICK-SOLVING SOLID DOSAGE FORM
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
BR112013005194A2 (pt) 2010-09-02 2016-05-03 Gruenenthal Gmbh forma de dosagem resistente à violação compreendendo sal inorgânico
TWI516286B (zh) 2010-09-02 2016-01-11 歌林達股份有限公司 含陰離子聚合物之抗破碎劑型
EA201400172A1 (ru) 2011-07-29 2014-06-30 Грюненталь Гмбх Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
BR112014001091A2 (pt) 2011-07-29 2017-02-14 Gruenenthal Gmbh comprimido resistente à adulteração que fornece liberação imediata do fármaco
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
EP2838512B1 (de) 2012-04-18 2018-08-22 Grünenthal GmbH Fälschungssichere und dose dumping sichere pharmazeutische darreichungsform
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
EP3003279A1 (de) 2013-05-29 2016-04-13 Grünenthal GmbH Manipulationssichere darreichungsform mit einem oder mehreren partikeln
US9737490B2 (en) 2013-05-29 2017-08-22 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
EP3073994A1 (de) 2013-11-26 2016-10-05 Grünenthal GmbH Herstellung einer pulverförmigen pharmazeutischen zusammensetzung mittels kryogenen mahlens
US9468606B2 (en) * 2014-03-31 2016-10-18 Johnson & Johnson Consumer Inc. Compostions and methods for enhancing the topical application of an acidic benefit agent
WO2015173195A1 (en) 2014-05-12 2015-11-19 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EA201692388A1 (ru) 2014-05-26 2017-05-31 Грюненталь Гмбх Лекарственная форма в виде множества частиц, защищенная от вызываемого этанолом сброса дозы
WO2016170097A1 (en) 2015-04-24 2016-10-27 Grünenthal GmbH Tamper-resistant dosage form with immediate release and resistance against solvent extraction
JP2018526414A (ja) 2015-09-10 2018-09-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 乱用抑止性の即放性製剤を用いた経口過剰摂取に対する保護
JP7782909B2 (ja) * 2019-09-03 2025-12-09 エルジー・エイチアンドエイチ・カンパニー・リミテッド 溶解性が向上した固体相の高分子を含む化粧料組成物
CN116481290A (zh) * 2022-12-28 2023-07-25 常州兰陵制药有限公司 葡萄糖酸钙结晶干燥装置及方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2166074A (en) 1937-04-09 1939-07-11 Sharp & Dohme Inc Gelatinous colloids
GB698767A (en) 1950-07-06 1953-10-21 Bayer Ag Readily soluble dry preparations of swelling substances
US2758644A (en) * 1953-07-30 1956-08-14 Virlouvet Jacques Control system for slatted roller blinds
US3234091A (en) 1955-07-08 1966-02-08 Ciba Geigy Corp Shaped medicaments and process for their manufacture
DE2017373A1 (de) 1969-04-15 1971-04-22 Orsymonde S A , Paris Lyophihsierte Produkte und Ver fahren zu ihrer Herstellung
GB1548022A (en) 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) 1977-07-20 1981-03-10 George K. E. Gregory Packages
JPS5913887B2 (ja) 1979-10-30 1984-04-02 株式会社ブリヂストン 溶融金属用濾過材
DE3404382A1 (de) 1984-02-08 1985-08-14 Anton Dr. 4400 Münster Härle Saugflasche zum absaugen von sekreten aus wundhoehlen
US5045565A (en) * 1987-03-09 1991-09-03 The Procter & Gamble Company Novel compounds, pharmaceutical compositions, and methods for treating inflammation and pain
US4697630A (en) * 1987-03-17 1987-10-06 General Clutch Corporation Tilt mechanism for venetian blinds
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) * 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5215756A (en) 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution

Also Published As

Publication number Publication date
CZ283882B6 (cs) 1998-06-17
HUT68224A (en) 1995-06-28
NZ252526A (en) 1995-09-26
AU677198B2 (en) 1997-04-17
RO112990B1 (ro) 1998-03-30
HU227532B1 (en) 2011-07-28
FI945198L (fi) 1994-11-04
IL105553A (en) 1998-01-04
TW380053B (en) 2000-01-21
FI945198A0 (fi) 1994-11-04
SG47430A1 (en) 1998-04-17
MY112231A (en) 2001-05-31
ES2136662T3 (es) 1999-12-01
DK0642334T3 (da) 2000-04-17
CN1085081A (zh) 1994-04-13
KR100194241B1 (ko) 1999-06-15
NO308065B1 (no) 2000-07-17
RU94046029A (ru) 1996-11-10
EP0642334A1 (de) 1995-03-15
SK280129B6 (sk) 1999-08-06
CL2004001180A1 (es) 2005-06-03
WO1993023017A1 (en) 1993-11-25
DE69326063D1 (de) 1999-09-23
RU2131244C1 (ru) 1999-06-10
SK132094A3 (en) 1995-07-11
BG62681B1 (bg) 2000-05-31
CZ265494A3 (en) 1995-02-15
GR3031180T3 (en) 1999-12-31
KR950700728A (ko) 1995-02-20
NO944207L (no) 1994-11-04
FI111333B (fi) 2003-07-15
HU211549A9 (en) 1995-12-28
HK1010693A1 (en) 1999-06-25
BG99158A (bg) 1995-05-31
DE69326063T2 (de) 2000-03-16
JPH07508019A (ja) 1995-09-07
AU4232293A (en) 1993-12-13
CY2175B1 (en) 2002-08-23
CA2135062C (en) 1999-05-25
IL105553A0 (en) 1993-08-18
PL172354B1 (pl) 1997-09-30
CA2135062A1 (en) 1993-11-25
NO944207D0 (no) 1994-11-04
EP0642334B1 (de) 1999-08-18

Similar Documents

Publication Publication Date Title
DE69326063D1 (de) Pharmazeutische und andere darreichungsformen
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
ATE493998T1 (de) Pharmazeutische zusammensetzung mit einem exendin-4-peptid
ID28003A (id) Turunan-turunan adamantana
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2107284T3 (es) Nuevas n-piridil-carboxamidas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
DE69119810D1 (de) Pyrogensorbentmittel
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
DE69113304D1 (de) Pharmazeutische, diätetische oder veterinäre Zusammensetzungen mit eumetabolischer Aktivität.
KR920002151A (ko) 15-케토-프로스타글란딘 화합물에 의한 염증성 질환 치료
KR910007531A (ko) 15-케토-프로스타글란딘 화합물을 이용한 간 담즙성 질병의 치료
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
NO894594D0 (no) Farmasoeytiske sammensetninger omfattende labdan diterpenoid-derivater og pyrimido(6,1-a)isoquinolin-4-ono-derivater.
ATE93527T1 (de) Peptide und deren benutzung.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
NZ228023A (en) 24(r)-scymnol; preparatory processes and pharmaceutical compositions
DE3866747D1 (de) Jod enthaltende pharmazeutische zubereitung.
MX9102087A (es) Complejos que contienen acidos s(+) fenilalcanos y acidos alfa-hidroxi alcanos.
IT1224250B (it) Associzione del depiprazolo con la morfina
DE59205625D1 (de) Perorale applikationsform für peptidarzneistoffe, insbesondere insulin
YU2394A (sh) Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida
SE9100284D0 (sv) Novel peptide
DE68907893D1 (de) Neue 1,3,4,-thiadiazolderivate und antigeschwulstmittel, die diese enthalten.
ITMI921084A1 (it) Struttura di macchina da cucire perfezionata, particolarmente studiata per la cucitura di calzature e simili